Association between seroprevalence of anti-chlamydial antibodies and long-term cardiovascular mortality in chronic hemodialysis patients

Atherosclerosis

Volumn 188, Issue 1, 2006, Pages 120-125

  Kato, Akihiko ^a   Takita, Takako ^b   Furuhashi, Mitsuyoshi ^b   Maruyama, Yukitaka ^b   Hishida, Akira ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Maruyama Hospital   (Japan)

Author keywords

C reactive protein; Cardiovascular death; Chlamydia pneumoniae; Hemodialysis; Serological test

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 6; PARATHYROID HORMONE; SERUM ALBUMIN;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; ISCHEMIC COLITIS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SEROPREVALENCE; SEX RATIO; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 33746521390     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.10.006     Document Type: Article

References (24)

1. Müller J., Nyvad O., Larsen N.A., Larsen N.A., and Pedersen E.B. Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in dialysis patients, renal transplant recipients and healthy controls. Scand J Clin Lab Invest 62 (2002) 503-509
2. Oh J., Wunsch R., Turzer M., et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106 (2002) 100-105
3. Stenvinkel P., Heimbürger O., Jogenstrand T., Kärnell A., and Samuelsson A. Does persistent infection with Chlamydia pneumoniae increase the risk of atherosclerosis in chronic renal failure?. Kidney Int 55 (1999) 2531-2532
4. Stenvinkel P., Heimbürger O., and Jogenstrand T. Elevated interlukin-6 predicts progressive carotid atherosclerosis in dialysis patients: Association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis 39 (2002) 274-282
5. Kato A., Odamaki M., Takita T., et al. Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients. Kidney Int 61 (2002) 1143-1152
6. Song H., Tasaki H., Yashiro A., et al. Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure. Clin Nephrol 56 (2001) 346-352
7. Haubitz M., and Brunkhorst R. C-reactive protein and chronic Chlamydia pneumoniae infection-long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 16 (2001) 809-815
8. Wolf S.C., Mayer O., Jurgens S., Vonthein R., and Risler T.E. Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients. Clin Nephrol 59 (2003) 273-279
9. Bellomo G., Lippi G., Saronio P., et al. Inflammation, infection and cardiovascular events in chronic hemodialysis patients: A prospective study. J Nephrol 16 (2003) 245-251
10. Haubitz M., Votsch K., Woywodt A., et al. Serological evidence of Chlamydia pneumoniae infection as a long-term predictor of cardiovascular death in renal transplant recipients. Transplantation 77 (2004) 1517-1521
11. Zoccali C., Mallamaci F., Tripepi G., et al. Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD). Kidney Int 64 (2003) 579-584
12. Numazaki K., Ikebe T., and Chiba S. Detection of serum antibodies against Chlamydial pneumoniae by ELISA. FEMS Immunol Med Microbiol 14 (1996) 179-183
13. Maeda N., Sawayama Y., Tatsukawa M., et al. Carotid artery lesions and atherosclerotic risk factors in Japanese hemodialysis patients. Atherosclerosis 169 (2003) 183-192
14. Rupp J., Hellwig-Burgel T., Wobbe V., et al. Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo. Proc Natl Acad Sci USA 102 (2005) 3447-3452
15. Saikku P., Leinonen M., Tenkanen L., et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 116 (1992) 273-278
16. Sander D., Winbeck K., Klingelhöfer J., Etgen T., and Conrad B. Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity. Circulation 109 (2004) 1010-1015
17. Kato A., Takita T., Maruyama Y., and Hishida A. Chlamydial infection and progression of carotid atherosclerosis in patients on regular hemodialysis. Nephrol Dial Transplant 19 (2004) 2539-2546
18. Zamorano J., Suarez A., Tejada J.G., et al. Prevalence of Chlamydia pneumoniae in the atherosclerotic plaque of patients with unstable angina and its relation with serology. Int J Cardiol 89 (2003) 273-279
19. Tsirpanlis G., Chatzipanagiotou S., Ioannidis A., et al. Detection of Chlamydia pneumoniae in peripheral blood mononuclear cells: correlation with inflammatory and atherosclerosis in haemodialysis patients. Nephrol Dial Transplant 18 (2003) 918-923
20. Zamorona J., Tejada J.G., Suárez A., et al. Chlamydia pneumoniae in the atherosclerotic plaques of patients with unstable angina undergoing coronary artery bypass grafting: does it have prognostic implications?. Int J Cardiol 90 (2003) 297-302
21. Wells B.J., Mainous A.G., and Dickerson L.M. Antibiotics for the secondary prevention of ischemic heart disease. A meta-analysis of randomized controlled trials. Arch Intern Med 164 (2004) 2156-2161
22. Zimmermann J., Herrlinger S., Pruy A., Metzger T., and Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55 (1999) 648-658
23. Andersson P., Rydberg E., and Willenheimer R. Primary hyperparathyroidism and heart disease-a review. Eur Heart J 25 (2004) 1776-1787
24. Young E.W., Albert J.M., Satayathum S., et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 67 (2005) 1179-1187